CAREFIB Consortium aims to reduce the burden of atrial fibrillation and its adverse outcome stroke in patients undergoing cardiac procedures. This consortium is divided into three major studies: a retrospective epidemiological CAREAVR study; a prospective CAREBANK biobank and a prospective LAA-CLOSURE trial.



See our selected publications.

Read more →

Research team

Get to know our research team.

Read more →